Postoperative Kinetics of Pentraxin 3 (PTX3) After Congenital Heart Surgery with Cardiopulmonary Bypass in Pediatric Patients

Overview

Journal Perioper Med (Lond)

Publisher Biomed Central

Date 2022 Aug 21

PMID 35989325

Authors

Radoslaw Jaworski

Katarzyna Dzierzanowska-Fangrat

Renata Grzywa-Czuba

Andrzej Kansy

Affiliations

Soon will be listed here.

Abstract

Background: Pentraxins are inflammatory proteins and markers of acute-phase responses. They are divided into short and long subgroups based on the length of the N-terminal region. The most studied short pentraxin is the C-reactive protein (CRP), which is known to be expressed in various inflammatory conditions, including surgical procedures. On the other hand, much less is known about the kinetics of long pentraxin 3 (PTX3) in surgical patients, especially in the pediatric population. The aim of this prospective study was to determine the early postoperative kinetics of PTX3 in relation to procalcitonin (PCT) and CRP levels in children undergoing congenital heart surgery with cardiopulmonary bypass (CPB).

Methods: A total of 21 children (9 boys and 12 girls, mean age 12 months) were included in the study. Blood samples for determination of CRP, PCT, and PTX3 levels were collected before the surgery and then immediately after its completion (postoperative day 0, POD 0) and subsequently at POD 1, 2, and 3.

Results: Serum PTX3 concentrations increased significantly between POD 0 and POD 1 (mean values were 12.2 and 72.4 ng/ml, respectively, p<0.001), decreased between POD 1 and POD 2 (mean values were 72.4 and 23.6 ng/ml, respectively, p<0.001), and normalized on POD 3 (the mean value was 1.2 ng/ml).

Conclusions: PTX3 concentrations are markedly elevated during the first postoperative day. Under normal circumstances, PTX3 rises and falls quickly, and its second rise in the early postoperative period may be abnormal, however, further studies are necessary.

References

Garlanda C, Bottazzi B, Magrini E, Inforzato A, Mantovani A . PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer. Physiol Rev. 2018; 98(2):623-639. PMC: 5985957. DOI: 10.1152/physrev.00016.2017. View

Jaworski R, Kansy A, Dzierzanowska-Fangrat K, Maruszewski B . Antibiotic Prophylaxis in Pediatric Cardiac Surgery: Where Are We and Where Do We Go? A Systematic Review. Surg Infect (Larchmt). 2019; 20(4):253-260. DOI: 10.1089/sur.2018.272. View

Baumert M, Surmiak P, Szymkowiak M, Janosz A . The Assessment of Pentraxin 3: A Novel Biomarker in Early Detection of Infection in Newborns. Biomed Res Int. 2021; 2021:6638622. PMC: 8266451. DOI: 10.1155/2021/6638622. View

Giacomini A, Ghedini G, Presta M, Ronca R . Long pentraxin 3: A novel multifaceted player in cancer. Biochim Biophys Acta Rev Cancer. 2017; 1869(1):53-63. DOI: 10.1016/j.bbcan.2017.11.004. View

Ristagno G, Fumagalli F, Bottazzi B, Mantovani A, Olivari D, Novelli D . Pentraxin 3 in Cardiovascular Disease. Front Immunol. 2019; 10:823. PMC: 6481278. DOI: 10.3389/fimmu.2019.00823. View

Jaworski R, Haponiuk I, Irga-Jaworska N, Steffens M, Chojnicki M, Paczkowski K . Monitoring both procalcitonin and C-reactive protein in the early period after tetralogy of Fallot correction in children promotes rational antibiotic use. Adv Med Sci. 2017; 63(1):112-118. DOI: 10.1016/j.advms.2017.10.003. View

Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, Avanzini F . PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation. 2000; 102(6):636-41. DOI: 10.1161/01.cir.102.6.636. View

Marseglia G, De Amici M, Marseglia A, Caimmi S, Miraglia Del Giudice M, Leoni M . Pentraxin 3 serum levels in children with atopic dermatitis. J Biol Regul Homeost Agents. 2012; 26(1 Suppl):S105-8. View

Doni A, DAmico G, Morone D, Mantovani A, Garlanda C . Humoral innate immunity at the crossroad between microbe and matrix recognition: The role of PTX3 in tissue damage. Semin Cell Dev Biol. 2016; 61:31-40. PMC: 5419421. DOI: 10.1016/j.semcdb.2016.07.026. View

10.

Cieslik P, Hrycek A . Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications. Autoimmunity. 2011; 45(2):119-28. DOI: 10.3109/08916934.2011.611549. View

11.

Vilahur G, Badimon L . Biological actions of pentraxins. Vascul Pharmacol. 2015; 73:38-44. DOI: 10.1016/j.vph.2015.05.001. View

12.

Alphonso N, Anagnostopoulos P, Scarpace S, Weintrub P, Azakie A, Raff G . Perioperative antibiotic prophylaxis in paediatric cardiac surgery. Cardiol Young. 2007; 17(1):12-25. DOI: 10.1017/S1047951107000066. View

13.

Inoue K, Kodama T, Daida H . Pentraxin 3: a novel biomarker for inflammatory cardiovascular disease. Int J Vasc Med. 2012; 2012:657025. PMC: 3278926. DOI: 10.1155/2012/657025. View

14.

Muller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B . Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med. 2001; 29(7):1404-7. DOI: 10.1097/00003246-200107000-00017. View

15.

Oztan M, Aksoy Gokmen A, Ozdemir T, Muderris T, Kaya S, Koyluoglu G . Pentraxin-3: A strong novel biochemical marker for appendicitis in children. Am J Emerg Med. 2019; 37(10):1912-1916. DOI: 10.1016/j.ajem.2019.01.010. View

16.

Zlibut A, Bocsan I, Agoston-Coldea L . Pentraxin-3 and endothelial dysfunction. Adv Clin Chem. 2019; 91:163-179. DOI: 10.1016/bs.acc.2019.03.005. View

17.

Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I . The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention. Mediators Inflamm. 2014; 2014:608414. PMC: 3967811. DOI: 10.1155/2014/608414. View

18.

Ates U, Bahadir K, Ergun E, Gollu G, Durmaz M, Gunay F . Determination of pentraxin 3 levels in diagnosis of appendicitis in children. Pediatr Int. 2019; 62(5):624-628. DOI: 10.1111/ped.14131. View

19.

Farias J, Villarreal E, Dhargalkar J, Kleinhans A, Flores S, Loomba R . C-reactive protein and procalcitonin after congenital heart surgery utilizing cardiopulmonary bypass: When should we be worried?. J Card Surg. 2021; 36(11):4301-4307. DOI: 10.1111/jocs.15952. View

20.

Yamasaki K, Kurimura M, Kasai T, Sagara M, Kodama T, Inoue K . Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations. Clin Chem Lab Med. 2009; 47(4):471-7. DOI: 10.1515/CCLM.2009.110. View